Cargando…

Safety and costs of blood transfusion practices in dengue cases in Brazil

BACKGROUND: Dengue is a public health problem, and noncompliance with World Health Organization (WHO) recommendations for blood transfusion components is frequently reported. Moreover, economic impact studies of the WHO recommendations on the use of blood transfusion are scarce. METHODS: We compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado, Alessandra Aparecida Vieira, Negrão, Fábio Juliano, Croda, Júlio, de Medeiros, Elias Silva, Pires, Maria Aparecida dos Santos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613682/
https://www.ncbi.nlm.nih.gov/pubmed/31283788
http://dx.doi.org/10.1371/journal.pone.0219287
_version_ 1783433074064752640
author Machado, Alessandra Aparecida Vieira
Negrão, Fábio Juliano
Croda, Júlio
de Medeiros, Elias Silva
Pires, Maria Aparecida dos Santos
author_facet Machado, Alessandra Aparecida Vieira
Negrão, Fábio Juliano
Croda, Júlio
de Medeiros, Elias Silva
Pires, Maria Aparecida dos Santos
author_sort Machado, Alessandra Aparecida Vieira
collection PubMed
description BACKGROUND: Dengue is a public health problem, and noncompliance with World Health Organization (WHO) recommendations for blood transfusion components is frequently reported. Moreover, economic impact studies of the WHO recommendations on the use of blood transfusion are scarce. METHODS: We compared the cost and hospitalization time in a prospective observational study, by following hospitalised patients and analysing their medical records from 2010 and March 2016 to December 2017. We divided the patients into two groups: transfused (with or without WHO criteria for transfusion) and not transfused (with or without WHO criteria for transfusion). Generalised linear modelling was performed to identify the variable that could increase the costs and hospital stay. RESULTS: Among 323 patients, 52 were transfused, of whom 52% without criteria (n = 27), and 271 were not transfused, of which 4.4% (n = 12) with criteria. Hospitalisation costs were 41% higher in the transfused group without criteria than in those with criteria (median US$ 674.3 vs US$ 478 p = 0.293). Patients who were not transfused but met the WHO criteria for transfusion (n = 12) had longer mean hospitalisation time than did those who were not transfused (3.8±3.4 days versus 3.6±3.1 days; p = 0.022). The GLM analysis using hospital stay and costs as the dependent variable explained approximately 33.4% (R(2) = 0.334) of the hospitalisation time and 79.3% (R(2) = 0.793) of costs. Receiving a transfusion increased the hospitalization time by 1.29 days (p = 0.0007; IRR = 1.29), and the costs were 5.1 times higher than those without receiving blood components (IRR = 5.1; p< 0.001; median US$ 504.4 vs US$ 170.7). In contrast, patients who were transfused according to WHO criteria had a reduction in costs of approximately 96% (IRR = 0.044; p<0.001; β = -3.12) compared to that for those who were not transfused according to WHO criteria (without criteria). CONCLUSION: Transfusion without following WHO recommendations increased the time and cost of hospitalisation.
format Online
Article
Text
id pubmed-6613682
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-66136822019-07-23 Safety and costs of blood transfusion practices in dengue cases in Brazil Machado, Alessandra Aparecida Vieira Negrão, Fábio Juliano Croda, Júlio de Medeiros, Elias Silva Pires, Maria Aparecida dos Santos PLoS One Research Article BACKGROUND: Dengue is a public health problem, and noncompliance with World Health Organization (WHO) recommendations for blood transfusion components is frequently reported. Moreover, economic impact studies of the WHO recommendations on the use of blood transfusion are scarce. METHODS: We compared the cost and hospitalization time in a prospective observational study, by following hospitalised patients and analysing their medical records from 2010 and March 2016 to December 2017. We divided the patients into two groups: transfused (with or without WHO criteria for transfusion) and not transfused (with or without WHO criteria for transfusion). Generalised linear modelling was performed to identify the variable that could increase the costs and hospital stay. RESULTS: Among 323 patients, 52 were transfused, of whom 52% without criteria (n = 27), and 271 were not transfused, of which 4.4% (n = 12) with criteria. Hospitalisation costs were 41% higher in the transfused group without criteria than in those with criteria (median US$ 674.3 vs US$ 478 p = 0.293). Patients who were not transfused but met the WHO criteria for transfusion (n = 12) had longer mean hospitalisation time than did those who were not transfused (3.8±3.4 days versus 3.6±3.1 days; p = 0.022). The GLM analysis using hospital stay and costs as the dependent variable explained approximately 33.4% (R(2) = 0.334) of the hospitalisation time and 79.3% (R(2) = 0.793) of costs. Receiving a transfusion increased the hospitalization time by 1.29 days (p = 0.0007; IRR = 1.29), and the costs were 5.1 times higher than those without receiving blood components (IRR = 5.1; p< 0.001; median US$ 504.4 vs US$ 170.7). In contrast, patients who were transfused according to WHO criteria had a reduction in costs of approximately 96% (IRR = 0.044; p<0.001; β = -3.12) compared to that for those who were not transfused according to WHO criteria (without criteria). CONCLUSION: Transfusion without following WHO recommendations increased the time and cost of hospitalisation. Public Library of Science 2019-07-08 /pmc/articles/PMC6613682/ /pubmed/31283788 http://dx.doi.org/10.1371/journal.pone.0219287 Text en © 2019 Machado et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Machado, Alessandra Aparecida Vieira
Negrão, Fábio Juliano
Croda, Júlio
de Medeiros, Elias Silva
Pires, Maria Aparecida dos Santos
Safety and costs of blood transfusion practices in dengue cases in Brazil
title Safety and costs of blood transfusion practices in dengue cases in Brazil
title_full Safety and costs of blood transfusion practices in dengue cases in Brazil
title_fullStr Safety and costs of blood transfusion practices in dengue cases in Brazil
title_full_unstemmed Safety and costs of blood transfusion practices in dengue cases in Brazil
title_short Safety and costs of blood transfusion practices in dengue cases in Brazil
title_sort safety and costs of blood transfusion practices in dengue cases in brazil
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613682/
https://www.ncbi.nlm.nih.gov/pubmed/31283788
http://dx.doi.org/10.1371/journal.pone.0219287
work_keys_str_mv AT machadoalessandraaparecidavieira safetyandcostsofbloodtransfusionpracticesindenguecasesinbrazil
AT negraofabiojuliano safetyandcostsofbloodtransfusionpracticesindenguecasesinbrazil
AT crodajulio safetyandcostsofbloodtransfusionpracticesindenguecasesinbrazil
AT demedeiroseliassilva safetyandcostsofbloodtransfusionpracticesindenguecasesinbrazil
AT piresmariaaparecidadossantos safetyandcostsofbloodtransfusionpracticesindenguecasesinbrazil